Low sclerostin levels: a predictive marker of persistent inflammation in ankylosing spondylitis during anti-tumor necrosis factor therapy?
about
Serum Sclerostin Levels in Patients with Ankylosing Spondylitis and Rheumatoid Arthritis: A Systematic Review and Meta-AnalysisUpdate on ankylosing spondylitis: current concepts in pathogenesis.Fetuin-A is related to syndesmophytes in patients with ankylosing spondylitis: a case control study.Frontiers in the bioarchaeology of stress and disease: cross-disciplinary perspectives from pathophysiology, human biology, and epidemiology.Biomarkers for diagnosis, monitoring of progression, and treatment responses in ankylosing spondylitis and axial spondyloarthritis.To Wnt or not to Wnt: the bone and joint health dilemmaTumor necrosis factor alpha antagonists in the treatment of axial spondyloarthritis.Wnt signaling in ankylosing spondylitis.Seronegative arthritis in Latin America: a current review.Vitamin D and spondyloarthritis.The ASAS Criteria for Axial Spondyloarthritis: Strengths, Weaknesses, and Proposals for a Way Forward.The ongoing quest for biomarkers in Ankylosing Spondylitis.Urolithiasis as an extraarticular manifestation of ankylosing spondylitis.Chronic Periodontitis Is Associated With Spinal Dysmobility in Patients With Ankylosing Spondylitis.Higher Level of Dickkopf-1 is Associated with Low Bone Mineral Density and Higher Prevalence of Vertebral Fractures in Patients with Ankylosing Spondylitis.Serum levels of novel noggin and sclerostin-immune complexes are elevated in ankylosing spondylitis.Evaluation of periostin and factors associated with new bone formation in ankylosing spondylitis: Periostin may be associated with the Wnt pathway.Bone impairment assessed by HR-pQCT in juvenile-onset systemic lupus erythematosus.Serum Sclerostin as a Possible Biomarker in Ankylosing Spondylitis: A Case-Control Study.
P2860
Q33695718-4D12828A-FC1F-414D-889C-7B98127C419FQ34450732-0585F07E-76E2-47A5-9354-D152B22E5E29Q34457833-0AAAB870-89B4-41C3-8DA8-2F1ACE556107Q35216868-1CABF12F-4435-4846-98A6-2ABEE4F1A199Q35809286-5EDBFBD5-22B9-46CA-BE4C-DF4E8B17AFB5Q36794846-446549B2-4156-4C6C-8A12-450B5C45B8E1Q38198090-03CEC1FF-80CE-466B-AF4B-BFDF38EF85E5Q38211262-DDE0A678-2A1D-47E8-8972-16186281F7F0Q38229478-DF618D49-49F1-4836-AC7E-2AC8E16FF989Q38262855-58C8ED88-117A-4E1B-83F1-D145F5548DBAQ38569186-2DCBE7DE-090A-4B68-B63F-E442BBEB0710Q38607774-86A51858-2FE9-43BC-9BD6-AD5819AC2DC4Q38640178-29EA2B65-E00A-4B06-9FB4-8E52837A7F67Q40624375-563CC6C9-49B6-44D8-9904-EBFA376C5448Q41067642-D62A2290-0BA9-4F46-90AD-E4FF3D36167AQ46379699-34049A55-60B1-4188-980E-8F2B8E852D06Q47755895-587FC247-5CC5-4DED-B7D9-77A72B7EE013Q48895837-825BAC99-C2E0-451F-8F26-CA232CD88317Q55008112-CE3877E2-C585-437E-B663-20B464D2BDF9
P2860
Low sclerostin levels: a predictive marker of persistent inflammation in ankylosing spondylitis during anti-tumor necrosis factor therapy?
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Low sclerostin levels: a predi ...... tumor necrosis factor therapy?
@ast
Low sclerostin levels: a predi ...... tumor necrosis factor therapy?
@en
type
label
Low sclerostin levels: a predi ...... tumor necrosis factor therapy?
@ast
Low sclerostin levels: a predi ...... tumor necrosis factor therapy?
@en
prefLabel
Low sclerostin levels: a predi ...... tumor necrosis factor therapy?
@ast
Low sclerostin levels: a predi ...... tumor necrosis factor therapy?
@en
P2093
P2860
P356
P1476
Low sclerostin levels: a predi ...... tumor necrosis factor therapy?
@en
P2093
Ana C M Ribeiro
Carla G S Saad
Celio R Goncalves
Clovis A Silva
Julio C B Moraes
Liliam Takayama
Marcelo B Rodrigues
Ricardo M de Oliveira
Rosa M R Pereira
P2860
P2888
P356
10.1186/AR4055
P50
P577
2012-10-12T00:00:00Z
P5875
P6179
1037876848